105 related articles for article (PubMed ID: 16178535)
1. Heterobifunctional multivalent inhibitor-adaptor mediates specific aggregation between Shiga toxin and a pentraxin.
Solomon D; Kitov PI; Paszkiewicz E; Grant GA; Sadowska JM; Bundle DR
Org Lett; 2005 Sep; 7(20):4369-72. PubMed ID: 16178535
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and SAP-like pentraxin are both present in Limulus polyphemus haemolymph: crystal structure of Limulus SAP.
Shrive AK; Metcalfe AM; Cartwright JR; Greenhough TJ
J Mol Biol; 1999 Jul; 290(5):997-1008. PubMed ID: 10438598
[TBL] [Abstract][Full Text] [Related]
3. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.
Aquilina JA; Robinson CV
Biochem J; 2003 Oct; 375(Pt 2):323-8. PubMed ID: 12892563
[TBL] [Abstract][Full Text] [Related]
4. PPTX, a pentraxin domain-containing protein, interacts with the T1 domain of K v 4.
Harvey M; Karolat J; Sakai Y; Sokolowski B
J Neurosci Res; 2009 Jun; 87(8):1841-7. PubMed ID: 19185023
[TBL] [Abstract][Full Text] [Related]
5. Protein heterodimerization through ligand-bridged multivalent pre-organization: enhancing ligand binding toward both protein targets.
Liu J; Zhang Z; Tan X; Hol WG; Verlinde CL; Fan E
J Am Chem Soc; 2005 Feb; 127(7):2044-5. PubMed ID: 15713072
[TBL] [Abstract][Full Text] [Related]
6. Impact of the nature and size of the polymeric backbone on the ability of heterobifunctional ligands to mediate shiga toxin and serum amyloid p component ternary complex formation.
Kitov PI; Paszkiewicz E; Sadowska JM; Deng Z; Ahmed M; Narain R; Griener TP; Mulvey GL; Armstrong GD; Bundle DR
Toxins (Basel); 2011 Sep; 3(9):1065-88. PubMed ID: 22069757
[TBL] [Abstract][Full Text] [Related]
7. Structure of pentameric human serum amyloid P component.
Emsley J; White HE; O'Hara BP; Oliva G; Srinivasan N; Tickle IJ; Blundell TL; Pepys MB; Wood SP
Nature; 1994 Jan; 367(6461):338-45. PubMed ID: 8114934
[TBL] [Abstract][Full Text] [Related]
8. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
[TBL] [Abstract][Full Text] [Related]
10. The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.
Wang Z; Wang X; Zou H; Dai Z; Feng S; Zhang M; Xiao G; Liu Z; Cheng Q
Front Immunol; 2020; 11():1757. PubMed ID: 33013829
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
Hohenester E; Hutchinson WL; Pepys MB; Wood SP
J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
[TBL] [Abstract][Full Text] [Related]
12. Membrane pore formation by pentraxin proteins from Limulus, the American horseshoe crab.
Harrington JM; Chou HT; Gutsmann T; Gelhaus C; Stahlberg H; Leippe M; Armstrong PB
Biochem J; 2008 Jul; 413(2):305-13. PubMed ID: 18370931
[TBL] [Abstract][Full Text] [Related]
13. Development of dialyzer with immobilized glycoconjugate polymers for removal of Shiga-toxin.
Miyagawa A; Watanabe M; Igai K; Kasuya MC; Natori Y; Nishikawa K; Hatanaka K
Biomaterials; 2006 Jun; 27(17):3304-11. PubMed ID: 16499963
[TBL] [Abstract][Full Text] [Related]
14. Pentraxins in innate immunity and inflammation.
Garlanda C; Bottazzi B; Salvatori G; De Santis R; Cotena A; Deban L; Maina V; Moalli F; Doni A; Veliz-Rodriguez T; Mantovani A
Novartis Found Symp; 2006; 279():80-6; discussion 86-91, 216-9. PubMed ID: 17278387
[TBL] [Abstract][Full Text] [Related]
15. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.
Mauri T; Coppadoro A; Bellani G; Bombino M; Patroniti N; Peri G; Mantovani A; Pesenti A
Crit Care Med; 2008 Aug; 36(8):2302-8. PubMed ID: 18596636
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component.
Mikolajek H; Kolstoe SE; Pye VE; Mangione P; Pepys MB; Wood SP
J Mol Recognit; 2011; 24(2):371-7. PubMed ID: 21360619
[TBL] [Abstract][Full Text] [Related]
18. High-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells.
Rivieccio V; Esposito A; Bellofiore P; Palladino P; Sassano M; Colombo M; Verdoliva A
Protein Expr Purif; 2007 Jan; 51(1):49-58. PubMed ID: 16931047
[TBL] [Abstract][Full Text] [Related]
19. In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins.
Kitov PI; Mulvey GL; Griener TP; Lipinski T; Solomon D; Paszkiewicz E; Jacobson JM; Sadowska JM; Suzuki M; Yamamura K; Armstrong GD; Bundle DR
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16837-42. PubMed ID: 18955695
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for furin-induced cleavage and activation of Shiga toxin.
Kurmanova A; Llorente A; Polesskaya A; Garred O; Olsnes S; Kozlov J; Sandvig K
Biochem Biophys Res Commun; 2007 May; 357(1):144-9. PubMed ID: 17407762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
